CR GROUP L.P. sold 50.3% of their position (10.40M shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $3.81M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/21/2023ACC: 0001209191-23-050273
-10.40M
Net shares
Net seller
$3.81M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
10.40M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−4.16M
Price / share
$0.37
Trade value
$1.52M
% of position
21.5%
9/19/2023
19.33M→15.17M
Common Stock
Indirect
Shares
−2.59M
Price / share
$0.37
Trade value
$948.05K
% of position
21.5%
9/19/2023
12.04M→9.45M
Common Stock
Indirect
Shares
−831.94K
Price / share
$0.37
Trade value
$304.49K
% of position
21.5%
9/19/2023
3.87M→3.03M
Common Stock
Indirect
Shares
−2.82M
Price / share
$0.37
Trade value
$1.03M
% of position
21.5%
9/19/2023
13.11M→10.29M
Total
Net shares
−10.40M
Net value
-$3.81M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/19/2023 | S · Sale | −4.16M | $0.37 | $1.52M | 21.5% | 19.33M | 15.17M |
| Common Stock Indirect | 9/19/2023 | S · Sale | −2.59M | $0.37 | $948.05K | 21.5% | 12.04M | 9.45M |
| Common Stock Indirect | 9/19/2023 | S · Sale | −831.94K | $0.37 | $304.49K | 21.5% | 3.87M | 3.03M |
| Common Stock Indirect | 9/19/2023 | S · Sale | −2.82M | $0.37 | $1.03M | 21.5% | 13.11M | 10.29M |
| Total | −10.40M | -$3.81M | ||||||
Derivative Transactions0
No derivative transactions reported